Senior insider sale
SVP, Chief Financial Officer at SANA BIOTECHNOLOGY, INC. — senior position signals high conviction
$474.8K
163.34K shares
What this filing means
HARDY NATHAN plans to sell 163.34K shares of SANA BIOTECHNOLOGY, INC. valued at approximately $474.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/26/2024ACC: 0001963745-24-000051
Officer· SVP, Chief Financial Officer
Since Feb 2021
163.34K
Shares to sell
$474.8K
Approx. market value
91.61K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Founders Stock
Cash
7/23/2019
91.61KTotal acquired91.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/23/2019 | Founders Stock Cash | 91.61K | — |
| Total | 91.61K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
25.93K
Market value
$65.0K
11/25/2024
—Completed
Units to sell
45.80K
Market value
$180.8K
10/21/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
91.61K
Market value
$229.0K
11/26/2024
Total
Units
163.34K
Value
$474.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/25/2024 | 25.93K | $65.0K | — | Completed |
10/21/2024 | 45.80K | $180.8K | — | Completed |
| Planned — Approximate Date | ||||
11/26/2024 | 91.61K | $229.0K | Nasdaq | Planned |
| Total | 163.34K | $474.8K | ||